Revive Therapeutics Ltd (RVVTF)

[Classic Warrior]

Classic Warrior does not usually beg, but this time he will beg to differ. Companies routinely make modifications to trials to see how they are going. That is how they know to stop a trial yielding bad results to save money, tweak it, or to continue when things look good. We know enrollment was a problem, so perhaps Pharm Olam saw some interesting data and recommended that Revive expands. We know we started late. Your reference was not fair. The HALT is in reference to the "B" results, not funding on the psychedelic side. lol

ps. Anyway, $RVVTF recovered nicely today as we inch closer to results. Hang in there, buddy; you will be glad you did.